Galbraith Kenneth

Galbraith Kenneth is listed in filings as Chair & CEO at Zymeworks Inc.. This profile follows SEC Form 4 activity through Jan 12, 2026, including sale activity. Recent filings connect the profile to Zymeworks Inc. (ZYME). The current snapshot covers public activity from Jan 6, 2025 to Jan 12, 2026. Reported amounts are shown as $5.0M to $795.2K. The page organizes purchases, sales, issuer links, reported share activity, and filing evidence for review as public disclosure data.